{"acquisitions":[],"changes":[],"country":"CH","description":"Mosanna Therapeutics is building a nasal-spray drug for obstructive sleep apnea that reactivates upper-airway muscles during sleep instead of forcing the airway open mechanically. It targets the millions of OSA patients who reject or fail CPAP. The pharmacological approach restores a natural reflex rather than competing on mask comfort.","domain":"mosanna.com","employees":null,"founded":2023,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":47.558108,"lng":7.587826,"location":"Basel Switzerland","multiples":[],"name":"Mosanna Therapeutics","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":80000000,"connectionsAmong":[],"currency":"USD","date":"2025-06-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"mosanna-com-2025-06-01-series-a","source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-05","status":"attributed","url":null},"status":"attributed","type":"series-a","url":null}],"slug":"mosanna-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-05","status":"attributed","url":null},{"fact":"existence","publisher":"mosanna.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://mosanna.com"},{"fact":"description","publisher":"mosanna.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://mosanna.com"}],"stage":"series-a","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["WordPress 7.0","Apache HTTP Server","MonsterInsights 10.2.0","Yoast SEO 27.6","Google Analytics","Google Tag Manager","Slider Revolution","jQuery Migrate 3.4.1","PHP","DoubleClick Floodlight","MySQL","jquery 3."],"totalRaisedUsd":80000000,"traction":[],"updatedAt":"2026-05-05","valuations":[]}